Tergus Pharma and MedPharm are now one company!
+
The two premier topical experts have joined forces to create the world’s leading topical CDMO with global reach, experienced leadership, strong financial backing, and expanded end-to-end capabilities from early stage development through full commercial production of topical drug products.
Click here for the official press release.
GUILDFORD, United Kingdom and DURHAM, N.C., July 8, 2024 — MedPharm, Ltd., an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners... View Article
Guildford, UK and Durham, NC, May 2024 – MedPharm’s Chief Scientific Officer, Dr. Jon Lenn, will present on the chemical... View Article
MedPharm scientists have expanded on existing wounding models to develop improved methods for open and closed wounds. These models enable... View Article
In a recent Analytical Special Feature with Drug Development & Delivery, industry experts weigh in about the the impacts of... View Article
Guildford, UK and Durham, NC, February 20, 2024 – MedPharm, a global topical and transdermal CDMO, today announced several Board... View Article
MedPharm, Ltd., a global topical and transdermal CDMO, announced today that Daniel Morland has joined the company’s Senior Leadership Team... View Article
MedPharm, a global topical and transdermal CDMO, announced today that Lynn Allen has been named Chief Executive Officer (CEO), effective... View Article
MedPharm, a global Contract Development and Manufacturing Organization that specializes in topical and transdermal drug product development, recently completed a... View Article
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer October 2023, pages 92-94. © Samedan Ltd Unlike solid dosage drug products... View Article
MedPharm is pleased to announce that it has been selected as a finalist in two CPHI Pharma Award Categories. MedPharm’s... View Article
The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialization, ensuring... View Article
MedPharm Scientific Advisory Committee Chair and Co-founder, Professor Marc Brown, has been included in The Medicine Maker’s 2023 Power List.... View Article
MedPharm, a global CDMO focused on topical and transdermal development and manufacturing, recently announced the appointment of a new U.S.... View Article
MedPharm General Manager, Dr. Jessica Neil, has been selected as one of the Triangle Business Journal‘s 2023 Women in Business Award... View Article
The MedPharm team is excited to announce that the £1.5m renovation and expansion of our Surrey campus is now complete.... View Article
Oral drug delivery treatments remain the most popular due to their convenience and ease of administration. However, as more complex... View Article
The development and manufacture of topical generic products poses various challenges for pharma companies and their CDMOs, particularly when it... View Article